On the Design of Combination Cancer Therapy

13Citations
Citations of this article
92Readers
Mendeley users who have this article in their library.

Abstract

Combination therapy programs are the hallmark of the successful treatment of all forms of human malignancies. In this issue of Cell, Palmer and Sorger present data suggesting that cell culture results indicative of synergistic anticancer drug interactions rarely translate clinically and that the results of combination therapies in mouse models or human clinical trials, even if successful, are best explained by the independent activities of the individually administered drugs. Combination therapy programs are the hallmark of the successful treatment of all forms of human malignancies. In this issue of Cell, Palmer and Sorger present data suggesting that cell culture results indicative of synergistic anticancer drug interactions rarely translate clinically and that the results of combination therapies in mouse models or human clinical trials, even if successful, are best explained by the independent activities of the individually administered drugs.

Cite

CITATION STYLE

APA

Doroshow, J. H., & Simon, R. M. (2017, December 14). On the Design of Combination Cancer Therapy. Cell. Cell Press. https://doi.org/10.1016/j.cell.2017.11.035

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free